Package 69517-002-05

{"route": ["ORAL"], "spl_id": "3e97c632-9a87-674e-e063-6294a90a72a6", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0369517002052"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["1d4fbc45-ef89-45ab-bc6d-41f30b468ac7"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["HealthLife of USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (69517-002-05)", "package_ndc": "69517-002-05", "marketing_start_date": "20250912"}], "brand_name": "Extra Strength Aspirin 325 mg", "product_id": "69517-002_3e97c632-9a87-674e-e063-6294a90a72a6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "69517-002", "generic_name": "Aspirin", "labeler_name": "HealthLife of USA LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Extra Strength Aspirin 325 mg", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250912", "listing_expiration_date": "20261231"}